RFG Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
3,231
+850
+36% +$408K 0.03% 429
2026
Q1
$1.17M Buy
2,381
+593
+33% +$322K 0.02% 505
2025
Q4
$1.04M Sell
1,788
-334
-16% -$189K 0.02% 511
2025
Q3
$1.03M Sell
2,122
-640
-23% -$298K 0.02% 481
2025
Q2
$1.12M Sell
2,762
-1,973
-42% -$825K 0.03% 417
2025
Q1
$2.36M Buy
4,735
+1,233
+35% +$668K 0.06% 241
2024
Q4
$1.82M Sell
3,502
-151
-4% -$83K 0.05% 272
2024
Q3
$2.26M Buy
3,653
+43
+1% +$25.5K 0.07% 221
2024
Q2
$2M Sell
3,610
-87
-2% -$49.8K 0.07% 216
2024
Q1
$2.15M Buy
3,697
+365
+11% +$205K 0.07% 206
2023
Q4
$1.77M Buy
3,332
+494
+17% +$239K 0.07% 218
2023
Q3
$1.44M Buy
2,838
+332
+13% +$177K 0.06% 218
2023
Q2
$1.31M Sell
2,506
-130
-5% -$70.2K 0.06% 234
2023
Q1
$1.52M Sell
2,636
-3
-0.1% -$1.69K 0.07% 198
2022
Q4
$1.55M Sell
2,639
-348
-12% -$184K 0.08% 192
2022
Q3
$1.47M Buy
2,987
+5
+0.2% +$2.8K 0.08% 184
2022
Q2
$1.76M Buy
2,982
+55
+2% +$30.3K 0.1% 158
2022
Q1
$1.73M Sell
2,927
-18
-0.6% -$10.3K 0.11% 125
2021
Q4
$1.97M Buy
2,945
+214
+8% +$134K 0.14% 104
2021
Q3
$1.56M Buy
2,731
+407
+18% +$223K 0.13% 118
2021
Q2
$1.17M Buy
2,324
+205
+10% +$96.7K 0.1% 145
2021
Q1
$967K Buy
2,119
+84
+4% +$40.1K 0.11% 153
2020
Q4
$1.04M Sell
2,035
-183
-8% -$85.8K 0.14% 140
2020
Q3
$979K Buy
2,218
+147
+7% +$60.7K 0.14% 139
2020
Q2
$750K Buy
2,071
+163
+9% +$54.6K 0.12% 162
2020
Q1
$541K Buy
1,908
+413
+28% +$130K 0.1% 175
2019
Q4
$486K Buy
1,495
+678
+83% +$206K 0.08% 201
2019
Q3
$238K Buy
817
+64
+8% +$18.3K 0.05% 282
2019
Q2
$220K Buy
+753
New +$207K 0.05% 282
2018
Q4
Sell
-1,096
Closed -$268K 307
2018
Q3
$268K Buy
+1,096
New +$252K 0.07% 241

Other funds holding TMO

RFG Advisory's TMO Position: Q2 2026 in Review

RFG Advisory increased its Thermo Fisher Scientific (TMO) stake by 36% in Q2 2026, buying an estimated $408K and bringing the position to 3,231 shares worth $1.62M. The position accounts for 0.03% of the portfolio, ranked #429.

RFG Advisory first reported a position in TMO in Q3 2018 and has held it in 30 quarters since. The position peaked at $2.36M in Q1 2025. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • RFG Advisory held 3,231 shares of Thermo Fisher Scientific worth $1.62M as of Q2 2026.
  • RFG Advisory bought 850 Thermo Fisher Scientific shares in Q2 2026, an estimated $408K.
  • Thermo Fisher Scientific made up 0.03% of RFG Advisory's portfolio in Q2 2026, its #429 holding.
  • RFG Advisory first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 30 quarters since.
  • RFG Advisory's Thermo Fisher Scientific position peaked at $2.36M in Q1 2025.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.